← back to search

Tim Lancaster

Henry Ford Health System · US
Area of research
Physiology · Molecular Biology
Research interest
Research interests include Smoking Behavior and Cessation, Nicotinic Acetylcholine Receptors Study, Behavioral Health and Interventions, and Substance Abuse Treatment and Outcomes.
h-index
66
citations
24,583
works
171
NIH funding
primary concept
email

Recent publications

Nicotine replacement therapy versus control for smoking cessation
Cochrane Database of Systematic Reviews 2018cited by 712position: lastdoi
Group behaviour therapy programmes for smoking cessation
Cochrane Database of Systematic Reviews 2017cited by 784position: lastdoi
Individual behavioural counselling for smoking cessation
Cochrane Database of Systematic Reviews 2017cited by 443position: firstdoi
Physician advice for smoking cessation
Cochrane Database of Systematic Reviews 2013cited by 1,911position: lastdoi
Relapse prevention interventions for smoking cessation
Cochrane Database of Systematic Reviews 2013cited by 471position: lastdoi
Nicotine replacement therapy for smoking cessation
Cochrane Database of Systematic Reviews 2012cited by 2,482position: lastdoi

Grants

No grants ingested yet.

Frequent collaborators

Jamie Hartmann‐Boyce · Primary Health Care4 papers (2012–2018)Chris Bullen · University of Auckland2 papers (2012–2018) · 1 papers (2013–2013) · 1 papers (2018–2018)Guillermo Sánchez · Novartis (Switzerland)1 papers (2013–2013)Rafael Perera · John Radcliffe Hospital1 papers (2012–2012) · 1 papers (2013–2013)Peter Hájek · Queen Mary University of London1 papers (2013–2013)M. J. Jarvis · University of London1 papers (2013–2013)Weiyu Ye · Cambridge University Hospitals NHS Foundation Trust1 papers (2018–2018)David Mant · University of Oxford1 papers (2012–2012)Kate Cahill · Argonne National Laboratory1 papers (2012–2012)